Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
Holding DRUG?
Track your performance easily

Bright Minds Biosciences (DRUG) Financial Statements

175 Followers

Bright Minds Biosciences Financial Overview

Bright Minds Biosciences's market cap is currently ―. The company's EPS TTM is $-0.681; its P/E ratio is -64.72; Bright Minds Biosciences is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Dec 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit-----
EBIT-C$ -2.26MC$ -2.66MC$ -4.48MC$ -4.82M
EBITDA-C$ -2.24MC$ -2.66MC$ -4.48MC$ -4.82M
Net Income Common Stockholders-C$ -2.34MC$ -2.66MC$ -4.49MC$ -4.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 6.75MC$ 11.21MC$ 8.64MC$ 11.47MC$ 15.12M
Total AssetsC$ 6.88MC$ 11.55MC$ 8.82MC$ 11.76MC$ 15.41M
Total DebtC$ 73.55KC$ 124.48KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -6.67MC$ -11.09MC$ -8.64MC$ -11.47MC$ -15.12M
Total LiabilitiesC$ 280.86KC$ 582.66KC$ 385.32KC$ 1.00MC$ 489.60K
Stockholders EquityC$ 6.60MC$ 10.97MC$ 8.43MC$ 10.76MC$ 14.92M
Cash Flow-
Free Cash Flow-C$ -2.66MC$ -2.86MC$ -3.65MC$ -4.95M
Operating Cash Flow-C$ -2.66MC$ -2.86MC$ -3.65MC$ -4.95M
Investing Cash Flow----C$ 0.00
Financing Cash Flow-C$ 2.25MC$ 12.00KC$ 1.68KC$ 118.25K
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Bright Minds Biosciences Debt to Assets

Bright Minds Biosciences Cash Flow

Bright Minds Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis